Link to this page
Physician Data Query
Last uploaded:
August 27, 2019
Jump to:
| Preferred Name | infliximab | |
| Synonyms |
INF Remsima Avakine Remicade INFLIX cA2 |
|
| Definitions |
A recombinant chimeric, mouse-human monoclonal antibody directed against tumor necrosis factor alpha (TNF-alpha), a protein involved in inflammation, cell survival, and apoptosis. Infliximab may be pro- apoptotic or anti-apoptotic, depending on cell type. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1789" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1789" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000038698 |
|
| altLabel |
INF Remsima Avakine Remicade INFLIX cA2
|
|
| Component of | ||
| cui |
C1522155 C3886461 C0723012 C0666743
|
|
| Date last modified |
2018-09-24
|
|
| definition |
A recombinant chimeric, mouse-human monoclonal antibody directed against tumor necrosis factor alpha (TNF-alpha), a protein involved in inflammation, cell survival, and apoptosis. Infliximab may be pro- apoptotic or anti-apoptotic, depending on cell type. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1789" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1789" NCI Thesaurus)
|
|
| Legacy PDQ ID |
11355
|
|
| LT |
TRD
|
|
| NCI ID |
C1789
|
|
| notation |
CDR0000038698
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
infliximab
|
|
| tui |
T116 T129 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping